In Silico Identification and Biological Evaluation of Novel Selective Serum/Glucocorticoid-Inducible Kinase 1 Inhibitors Based on the Pyrazolo-Pyrimidine Scaffold

The serum/glucocorticoid-inducible kinase 1 (Sgk1) has demonstrated antiapoptotic function and the capability to regulate cell survival, proliferation, and differentiation. A pivotal role of Sgk1 in carcinogenesis and in resistance to anticancer therapy has been suggested. With the aim of identifying new Sgk1 modulators, 322 pyrazolo-pyrimidine derivatives have been virtually screened with respect to a crystallographic model of Sgk1. The top five ranked compounds have been evaluated demonstrating Sgk1 inhibition in vitro and selectivity compared to RAC-alpha serine/threonine-protein kinase (Akt1).

[1]  Simeon I. Taylor,et al.  sgk: an essential convergence point for peptide and steroid hormone regulation of ENaC-mediated Na+ transport. , 2002, American journal of physiology. Cell physiology.

[2]  G. Cuda,et al.  Sgk1 enhances RANBP1 transcript levels and decreases taxol sensitivity in RKO colon carcinoma cells , 2013, Oncogene.

[3]  Tracey Clark,et al.  Design of selective, ATP-competitive inhibitors of Akt. , 2010, Journal of medicinal chemistry.

[4]  A. C. Maiyar,et al.  Expression of the Serum- and Glucocorticoid-inducible Protein Kinase, Sgk, Is a Cell Survival Response to Multiple Types of Environmental Stress Stimuli in Mammary Epithelial Cells* , 2003, The Journal of Biological Chemistry.

[5]  C. Haft,et al.  Activation of Serum- and Glucocorticoid-induced Protein Kinase (Sgk) by Cyclic AMP and Insulin* , 2001, The Journal of Biological Chemistry.

[6]  Baoguang Zhao,et al.  Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[7]  Won Young Tak,et al.  Gene expression profile analysis in human hepatocellular carcinoma by cDNA microarray. , 2002, Molecules and cells.

[8]  M. Gishizky,et al.  SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling , 2000, Molecular and Cellular Biology.

[9]  C. Brullo,et al.  Hit Identification and Biological Evaluation of Anticancer Pyrazolopyrimidines Endowed with Anti‐inflammatory Activity , 2010, ChemMedChem.

[10]  Dana L. Miller,et al.  C. Elegans Are Protected from Lethal Hypoxia by an Embryonic Diapause , 2009, Current Biology.

[11]  M. Radi,et al.  Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study. , 2011, Journal of medicinal chemistry.

[12]  D. Kwiatkowski,et al.  mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation. , 2008, Molecular cell.

[13]  M. Modugno,et al.  Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation. , 2006, Journal of medicinal chemistry.

[14]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[15]  F. Lang,et al.  Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation , 2009, Journal of Molecular Medicine.

[16]  P. Visca,et al.  Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas , 2012, Journal of experimental & clinical cancer research : CR.

[17]  P. Cohen,et al.  The selectivity of protein kinase inhibitors: a further update. , 2007, The Biochemical journal.

[18]  Vito Barbieri,et al.  IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells , 2007, Journal of Molecular Medicine.

[19]  P. Visca,et al.  Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas , 2012, Journal of Experimental & Clinical Cancer Research.

[20]  N. Laping,et al.  Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic. , 2008, Cancer research.

[21]  C. Brullo,et al.  Identification of a novel pyrazolo[3,4-d]pyrimidine able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in mice. , 2007, Journal of medicinal chemistry.

[22]  P. Fossa,et al.  Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cells. , 2004, Journal of medicinal chemistry.

[23]  K. Boini,et al.  EMD638683, a Novel SGK Inhibitor with Antihypertensive Potency , 2011, Cellular Physiology and Biochemistry.

[24]  Baoguang Zhao,et al.  Crystal structure of the kinase domain of serum and glucocorticoid‐regulated kinase 1 in complex with AMP–PNP , 2007, Protein science : a publication of the Protein Society.

[25]  Suzanne D. Conzen,et al.  Glucocorticoid Receptor-mediated Protection from Apoptosis Is Associated with Induction of the Serine/Threonine Survival Kinase Gene, sgk-1 * , 2001, The Journal of Biological Chemistry.

[26]  Dan Liu,et al.  Identification of CISK, a new member of the SGK kinase family that promotes IL-3-dependent survival , 2000, Current Biology.

[27]  Tracey Clark,et al.  Synthesis and structure based optimization of novel Akt inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[28]  Peter Ballard,et al.  Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases. , 2013, Journal of medicinal chemistry.

[29]  B. Brandhuber,et al.  An ATP-Site On-Off Switch That Restricts Phosphatase Accessibility of Akt , 2012, Science Signaling.

[30]  S. Conzen,et al.  Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer , 2013, Clinical Cancer Research.

[31]  R. Pearson,et al.  AKT-independent PI3-K signaling in cancer – emerging role for SGK3 , 2013, Cancer management and research.

[32]  Wei Wu,et al.  Microarray Analysis Reveals Glucocorticoid-Regulated Survival Genes That Are Associated With Inhibition of Apoptosis in Breast Epithelial Cells , 2004, Cancer Research.

[33]  H. Rodemann,et al.  Inhibition of Colonic Tumor Growth by the Selective SGK Inhibitor EMD638683 , 2013, Cellular Physiology and Biochemistry.

[34]  S. Schenone,et al.  Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells. , 2006, European journal of cancer.